ArticleCancer medicine2021

IBSP, a potential recurrence biomarker, promotes the progression of colorectal cancer via Fyn/β-catenin signaling pathway.

Yan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.